Cerebral Vascular Applications, Inc. (CVA)
CVA develops proprietary, minimally invasive medical devices that assist in a patented surgical procedure intended to reduce the incidence of stroke and thromboembolism associated with atrial fibrillation (AF).
CVA has raised a total of $4.4 million investment capital to date.
2905 Premiere Parkway, Suite 150
Duluth, GA 30097